Viridian Therapeutics, Inc.\DE (VRDN) Other Accumulated Expenses (2013 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) reported Other Accumulated Expenses of $148,000 for Q4 2016, up 43.7% from $103,000 a year earlier but down 35.1% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Other Accumulated Expenses (2013 - 2016) Analysis & Trends
Dating back to Q4 2013, Viridian Therapeutics, Inc.\DE's Other Accumulated Expenses record includes 12 quarters.
- Other Accumulated Expenses has increased for three consecutive years, with a three-year compound annual growth rate of 54.7% (FY2013 to FY2016).
- By year, Other Accumulated Expenses came in at $103,000 in FY2015 (+28.8%), $80,000 in FY2014 (+100.0%) and $40,000 in FY2013.
- Five-year quarterly Other Accumulated Expenses spans a low of $40,000 in Q4 2013 and a high of $228,000 in Q3 2016.
- Year over year, Other Accumulated Expenses gained in four of the last seven quarters, with growth averaging 31.9%.
- The high point for year-over-year Other Accumulated Expenses in five years was Q3 2016 (growth of 125.7%); the low point was Q2 2016 (a decline of 15.3%).
- Per Business Quant data, the three quarters before Q4 2016 came in at $228,000 (Q3 2016), $83,000 (Q2 2016) and $87,000 (Q1 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.20 Bn | 2.20 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 148,000.00 |
| Sep 30, 2016 | 228,000.00 |
| Jun 30, 2016 | 83,000.00 |
| Mar 31, 2016 | 87,000.00 |
| Dec 31, 2015 | 103,000.00 |
| Sep 30, 2015 | 101,000.00 |
| Jun 30, 2015 | 98,000.00 |
| Mar 31, 2015 | 95,000.00 |
| Dec 31, 2014 | 80,000.00 |
| Sep 30, 2014 | 116,693.00 |
| Jun 30, 2014 | 60,466.00 |
| Dec 31, 2013 | 40,000.00 |
API Access
Viridian Therapeutics, Inc.\DE Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();